Literature DB >> 9311811

Coinfection of human foreskin fragments with multiple human papillomavirus types (HPV-11, -40, and -LVX82/MM7) produces regionally separate HPV infections within the same athymic mouse xenograft.

N D Christensen1, W A Koltun, N M Cladel, L R Budgeon, C A Reed, J W Kreider, P A Welsh, S D Patrick, H Yang.   

Abstract

The athymic mouse xenograft system was used to prepare infectious stocks of two additional anogenital tissue-targeting human papillomaviruses (HPVs) in a manner similar to that for the development of infectious stocks of HPV-11. An anal condyloma from a transplant patient was used as material for extraction of infectious virus, and human foreskin fragments were incubated with the virus suspension and transplanted subrenally into athymic mice. Partial viral sequencing indicated that two rare HPV types (HPV-40 and HPVLVX82/MM7) were concurrently present in both the patient condyloma and the foreskin xenografts, and passage of both types was achieved as a mixed infection with HPV-40 predominating. Xenografts that developed from simultaneous infection of human foreskin fragments with HPV-11, -40, and -LVX82/MM7 virions produced regionally separate areas of HPV-11 and -40 infection as determined by in situ hybridization. In addition, in situ hybridization with HPV-40 and HPVLVX82/MM7 DNA probes demonstrated that both of these HPV types were present as adjacent but separate infections within the same anal condyloma of the transplant patient. These studies indicate that multiple HPV types can simultaneously infect genital tissue and that each HPV type predominantly maintains regional separation within the same papilloma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311811      PMCID: PMC192078          DOI: 10.1128/JVI.71.10.7337-7344.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Identification of the alpha6 integrin as a candidate receptor for papillomaviruses.

Authors:  M Evander; I H Frazer; E Payne; Y M Qi; K Hengst; N A McMillan
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Cervical papillomaviruses segregate within morphologically distinct precancerous lesions.

Authors:  C P Crum; M Mitao; R U Levine; S Silverstein
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

Review 3.  The Shope papilloma-carcinoma complex of rabbits: a model system of neoplastic progression and spontaneous regression.

Authors:  J W Kreider; G L Bartlett
Journal:  Adv Cancer Res       Date:  1981       Impact factor: 6.242

4.  Laboratory production of infectious stocks of rabbit oral papillomavirus.

Authors:  N D Christensen; N M Cladel; C A Reed; L R Budgeon; P A Welsh; S D Patrick; J W Kreider
Journal:  J Gen Virol       Date:  1996-08       Impact factor: 3.891

5.  Multicentric human papillomavirus infections of the female genital tract: correlation of viral types with abnormal mitotic figures, colposcopic presentation, and location.

Authors:  C Bergeron; A Ferenczy; K V Shah; Z Naghashfar
Journal:  Obstet Gynecol       Date:  1987-05       Impact factor: 7.661

6.  Laboratory production in vivo of infectious human papillomavirus type 11.

Authors:  J W Kreider; M K Howett; A E Leure-Dupree; R J Zaino; J A Weber
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

7.  In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Authors:  R B Roden; H L Greenstone; R Kirnbauer; F P Booy; J Jessie; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  Frequency and distribution of papillomavirus structural antigens in verrucae, multiple papillomas, and condylomata of the oral cavity.

Authors:  A B Jenson; W D Lancaster; D P Hartmann; E L Shaffer
Journal:  Am J Pathol       Date:  1982-05       Impact factor: 4.307

9.  Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata.

Authors:  J W Kreider; M K Howett; S A Wolfe; G L Bartlett; R J Zaino; T Sedlacek; R Mortel
Journal:  Nature       Date:  1985 Oct 17-23       Impact factor: 49.962

10.  Immunoperoxidase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas.

Authors:  R J Kurman; K H Shah; W D Lancaster; A B Jenson
Journal:  Am J Obstet Gynecol       Date:  1981-08-15       Impact factor: 8.661

View more
  9 in total

1.  Immunohistochemical analysis, human papillomavirus DNA detection, hormonal manipulation, and exogenous gene expression of normal and dysplastic human cervical epithelium in severe combined immunodeficiency mice.

Authors:  J A Taylor; K Tewari; S Y Liao; C C Hughes; L P Villarreal
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Plant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study.

Authors:  T Kohl; I I Hitzeroth; D Stewart; A Varsani; V A Govan; N D Christensen; A-L Williamson; E P Rybicki
Journal:  Clin Vaccine Immunol       Date:  2006-08

3.  Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined immunodeficiency mouse.

Authors:  W Bonnez; C DaRin; C Borkhuis; K de Mesy Jensen; R C Reichman; R C Rose
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

5.  Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription.

Authors:  Michelle A Ozbun
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts.

Authors:  C A Harwood; P J Spink; T Surentheran; I M Leigh; E M de Villiers; J M McGregor; C M Proby; J Breuer
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

7.  Papillomavirus DNA complementation in vivo.

Authors:  Jiafen Hu; Nancy M Cladel; Lynn Budgeon; Karla K Balogh; Neil D Christensen
Journal:  Virus Res       Date:  2009-04-18       Impact factor: 3.303

Review 8.  Recent advances in preclinical model systems for papillomaviruses.

Authors:  Neil D Christensen; Lynn R Budgeon; Nancy M Cladel; Jiafen Hu
Journal:  Virus Res       Date:  2016-12-09       Impact factor: 3.303

9.  Replication interference between human papillomavirus types 16 and 18 mediated by heterologous E1 helicases.

Authors:  Seiichiro Mori; Rika Kusumoto-Matsuo; Yoshiyuki Ishii; Takamasa Takeuchi; Iwao Kukimoto
Journal:  Virol J       Date:  2014-01-24       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.